TABLE 1.
Characteristics of included studies.
| Study | PCI (n) | CABG (n) | Country | Male (%) | Smoker (%) | Diabetes (%) | Hypertension (%) | Unstable angina (%) | Previous MI (%) | Mean age (years) | Mean SYNTAX score | Type of stent used | Mean follow-up (years) | Mean LV ejection fraction (%) |
| ARTS | 600 | 605 | Netherlands, Brazil, United Kingdom, United States, Austria | 76.5 | 27.0 | 17.5 | 45.0 | 37.0 | 44.0 | 60.6 ± 10.8 | Bare metal stent | 4.8 ± 0.9 | 60.5 (12.5) | |
| BEST | 438 | 442 | South Korea, United States, Thailand, Malaysia, China | 71.5 | 20.1 | 41.3 | 67.1 | 42.2 | 9.8 | 64.5 ± 9.4 | 24.4 (7.8) | Everolimus DES | 4.0 ± 1.3 | 59.5 (8.3) |
| FREEDOM | 953 | 947 | United States, Canada, Italy, United Kingdom, Switzerland, France, Germany, Poland, Spain, Czechia, Israel, Brazil, Argentina, New Zealand, Australia, India | 71.4 | 15.7 | 100 | 85.0 | 31.0 | 26.2 | 62.1 ± 9.1 | 26.2 (8.6) | Paclitaxel and sirolimus DES | 3.5 ± 1.4 | 66.1 (11.3) |
| MASS-II | 205 | 203 | Brazil | 69.5 | 29.5 | 26.0 | 62.0 | 0 | 52.0 | 59.8 ± 9.0 | Bare metal stent | 4.5 ± 1.3 | 67 (8.5) | |
| SoS | 488 | 500 | United Kingdom, Sweden, Finland, Spain, Belgium, Italy, Canada, Germany, Switzerland, Norway | 79.0 | 15.0 | 14.5 | 45.0 | 20.0 | 44.0 | 61.4 ± 9.3 | Bare metal stent | 4.7 ± 0.9 | 57.0 | |
| SYNTAX | 903 | 897 | Netherlands, Germany, United Kingdom, United States, France, Denmark, Spain, Belgium, Italy, Hungary, Sweden, Finland, Portugal, Czechia, Austria | 77.5 | 20.0 | 25.5 | 66.5 | 29.0 | 32.0 | 65.1 ± 9.7 | 28.7 (11.5) | Paclitaxel DES | 4.4 ± 1.4 |
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; MI, myocardial infarction; DES, drug eluting stent; LV, left ventricle.